Phase III study of adjuvant therapy with encorafenib plus binimetinib compared to placebo in completely resected BRAFV600-mutant stage IIB/C melanoma: study design of the COLUMBUS-AD
Authors
Hauschild, A.Van Akkooi, A. C. J.
Long, G. V.
Mandala, M.
Kicinski, M.
Govaerts, A. S.
Klauck, I.
Ouali, M.
Lorigan, Paul C
Eggermont, A. M. M.
Affiliation
Klinik für Dermatologie, Venerologie und Allergologie, Universitäts-klinikum Schleswig-Holstein, Campus Kiel, Kiel, DeutschlandIssue Date
2022